文献速递流行病学与生物统计医学教育与科研方法

PRISMA与AMSTAR显示健康素养与癌症筛查系统评价质量良好

PRISMA and AMSTAR show systematic reviews on health literacy and cancer screening are of good quality.
PubMed 文献 · J Clin Epidemiol · 2018-04-11

该研究评估了2009至2017年发表的健康素养与癌症筛查领域系统评价(SR)的报告质量与方法学质量,共纳入19篇SR。PRISMA指数中位数为0.86,AMSTAR指数中位数为0.67;仅期刊影响因子与两项指数得分呈统计学显著正相关。作者结论认为该领域SR质量总体良好,并建议注册或发表方案、投稿时附PRISMA与AMSTAR清单并在投稿前自评。

要点

  • 该领域19篇SR的PRISMA指数中位数0.86、AMSTAR指数中位数0.67,总体质量良好。
  • 主要问题涉及方案注册或发表、评价者数量、灰色文献检索、排除文献清单及偏倚风险与疗效讨论未整合。
  • 仅期刊影响因子与PRISMA和AMSTAR指数得分呈统计学显著正相关。

核心结论

  • 健康素养与癌症筛查领域系统评价的质量总体良好。
  • 系统评价作者应注册或发表方案、投稿时附PRISMA和AMSTAR清单,并在投稿前自评。

研究设计与样本

  • 回顾性评估2009至2017年发表的系统评价,共纳入19篇SR。
  • 计算各SR对PRISMA和AMSTAR的依从性指数,并将指数得分对发表年份、地区、期刊影响因子、作者报告使用PRISMA及是否有资助声明进行回归分析。

主要发现

  • PRISMA指数中位数为0.86(IQR=0.11;范围0.32-1.00)。
  • AMSTAR指数中位数为0.67(IQR=0.30;范围0.22-1.00)。
  • 方法与报告问题涉及方案注册或发表、所用评价者数量、灰色文献检索、排除文献清单,以及偏倚风险与疗效讨论未整合。
  • 仅期刊影响因子与PRISMA和AMSTAR指数得分呈统计学显著正相关。

关键数值与推荐

  • PRISMA指数中位数0.86(IQR=0.11;范围0.32-1.00)。
  • AMSTAR指数中位数0.67(IQR=0.30;范围0.22-1.00)。
  • 纳入系统评价19篇,发表时间为2009至2017年。

临床怎么用

  • 系统评价作者应在投稿前完成方案注册或发表,并附PRISMA与AMSTAR清单。
  • 投稿前用PRISMA和AMSTAR对SR进行自评,重点核查评价者数量、灰色文献检索与排除文献清单。
  • 关注方案注册、偏倚风险与疗效讨论的整合,以提升报告与方法学质量。

局限性

  • 仅纳入2009至2017年发表的19篇SR,样本量有限。
  • 仅评估健康素养与癌症筛查领域,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objectives of this study were to evaluate the reporting and methodological quality of systematic reviews (SRs) on health literacy and cancer screening and to investigate factors that may influence overall quality. STUDY DESIGN AND SETTING: We reviewed SRs published between 2009 and 2017. We calculated indices to represent the included SRs' adherence to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) and A Measurement Tool to Assess Systematic Reviews (AMSTAR). To assess possible determinants of SRs' quality, we regressed the index scores on year and region of publication, journal impact factor, authors' reported use of PRISMA, and presence of funding statements. RESULTS: We included 19 SRs, and median index scores were 0.86 for PRISMA (interquartile range [IQR] = 0.11; range = 0.32-1.00) and 0.67 for AMSTAR (IQR = 0.30; range = 0.22-1.00). Methodological and reporting problems pertained to protocol registration or publication, number of raters used, gray literature searches, excluded article lists, and unintegrated discussions of risk of bias and efficacy. Only journal impact factor was statistically significantly associated (positively) with PRISMA and AMSTAR index scores. CONCLUSION: The quality of SRs on health literacy and cancer screening was generally good. Systematic reviewers should register or publish their protocols, include PRISMA and AMSTAR checklists when submitting SRs to journals, and self-evaluate their SRs before submission.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Sharma S, Oremus M. PRISMA and AMSTAR show systematic reviews on health literacy and cancer screening are of good quality. J Clin Epidemiol. 2018. PMID: 29654821. doi:10.1016/j.jclinepi.2018.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。